Autophagy plays a pro-apoptotic role in arsenic trioxide-induced cell death of liver cancer

IF 4.2 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Journal of Integrative Medicine-Jim Pub Date : 2024-05-01 DOI:10.1016/j.joim.2024.03.011
Zheng-ting Deng , Shu-fang Liang , Guo-kai Huang , Yu-qian Wang , Xiao-yu Tu , Ya-ni Zhang , Shu Li , Tao Liu , Bin-bin Cheng
{"title":"Autophagy plays a pro-apoptotic role in arsenic trioxide-induced cell death of liver cancer","authors":"Zheng-ting Deng ,&nbsp;Shu-fang Liang ,&nbsp;Guo-kai Huang ,&nbsp;Yu-qian Wang ,&nbsp;Xiao-yu Tu ,&nbsp;Ya-ni Zhang ,&nbsp;Shu Li ,&nbsp;Tao Liu ,&nbsp;Bin-bin Cheng","doi":"10.1016/j.joim.2024.03.011","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>The effects of arsenic trioxide (As<sub>2</sub>O<sub>3</sub>) on hepatocellular carcinoma have been documented widely. Autophagy plays dual roles in the survival and death of cancer cells. Therefore, we investigated the exact role of autophagy in As<sub>2</sub>O<sub>3</sub>-induced apoptosis in liver cancer cells.</p></div><div><h3>Methods</h3><p>The viability of hepatoma cells was determined using the MTT assay with or without fetal bovine serum. The rate of apoptosis in liver cancer cells treated with As<sub>2</sub>O<sub>3</sub> was evaluated using flow cytometry, Hoechst 33258 staining, and TUNEL assays. The rate of autophagy among liver cancer cells treated with As<sub>2</sub>O<sub>3</sub> was detected using immunofluorescence, Western blot assay and transmission electron microscopy.</p></div><div><h3>Results</h3><p>Upon treatment with As<sub>2</sub>O<sub>3</sub>, the viability of HepG2 and SMMC-7721 cells was decreased in a time- and dose-dependent manner. The apoptosis rates of both liver cancer cell lines increased with the concentration of As<sub>2</sub>O<sub>3</sub>, as shown by flow cytometry. Apoptosis in liver cancer cells treated with As<sub>2</sub>O<sub>3</sub> was also shown by the activation of the caspase cascade and the regulation of Bcl-2/Bax expression. Furthermore, As<sub>2</sub>O<sub>3</sub> treatment induced autophagy in liver cancer cells; this finding was supported by Western blot, immunofluorescence of LC3-II and beclin 1, and transmission electron microscopy. In liver cancer cells, As<sub>2</sub>O<sub>3</sub> inhibited the phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin <strong>(</strong>PI3K/AKT/mTOR) signal pathway that plays a vital role in both apoptosis and autophagy. The PI3K activator SC-79 partially reversed As<sub>2</sub>O<sub>3</sub><strong>-</strong>induced autophagy and apoptosis. Furthermore, inhibiting autophagy with 3-methyladenine partially reversed the negative effects of As<sub>2</sub>O<sub>3</sub> on cell viability. Serum starvation increased autophagy and amplified the effect of As<sub>2</sub>O<sub>3</sub> on cell death.</p></div><div><h3>Conclusion</h3><p>As<sub>2</sub>O<sub>3</sub> induces apoptosis and autophagy in liver cancer cells. Autophagy induced by As<sub>2</sub>O<sub>3</sub> may have a proapoptotic effect that helps to reduce the viability of liver cancer cells. This study provides novel insights into the effects of As<sub>2</sub>O<sub>3</sub> against liver cancer.</p><p>Please cite this article as: Deng ZT, Liang SF, Huang GK, Wang YQ, Tu XY, Zhang YN, Li S, Liu T, Cheng BB. Autophagy plays a pro-apoptotic role in arsenic trioxide-induced cell death of liver cancer. <em>J Integr Med</em>. 2024; 22(3): 295–302.</p></div>","PeriodicalId":48599,"journal":{"name":"Journal of Integrative Medicine-Jim","volume":null,"pages":null},"PeriodicalIF":4.2000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Integrative Medicine-Jim","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S209549642400044X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

The effects of arsenic trioxide (As2O3) on hepatocellular carcinoma have been documented widely. Autophagy plays dual roles in the survival and death of cancer cells. Therefore, we investigated the exact role of autophagy in As2O3-induced apoptosis in liver cancer cells.

Methods

The viability of hepatoma cells was determined using the MTT assay with or without fetal bovine serum. The rate of apoptosis in liver cancer cells treated with As2O3 was evaluated using flow cytometry, Hoechst 33258 staining, and TUNEL assays. The rate of autophagy among liver cancer cells treated with As2O3 was detected using immunofluorescence, Western blot assay and transmission electron microscopy.

Results

Upon treatment with As2O3, the viability of HepG2 and SMMC-7721 cells was decreased in a time- and dose-dependent manner. The apoptosis rates of both liver cancer cell lines increased with the concentration of As2O3, as shown by flow cytometry. Apoptosis in liver cancer cells treated with As2O3 was also shown by the activation of the caspase cascade and the regulation of Bcl-2/Bax expression. Furthermore, As2O3 treatment induced autophagy in liver cancer cells; this finding was supported by Western blot, immunofluorescence of LC3-II and beclin 1, and transmission electron microscopy. In liver cancer cells, As2O3 inhibited the phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) signal pathway that plays a vital role in both apoptosis and autophagy. The PI3K activator SC-79 partially reversed As2O3-induced autophagy and apoptosis. Furthermore, inhibiting autophagy with 3-methyladenine partially reversed the negative effects of As2O3 on cell viability. Serum starvation increased autophagy and amplified the effect of As2O3 on cell death.

Conclusion

As2O3 induces apoptosis and autophagy in liver cancer cells. Autophagy induced by As2O3 may have a proapoptotic effect that helps to reduce the viability of liver cancer cells. This study provides novel insights into the effects of As2O3 against liver cancer.

Please cite this article as: Deng ZT, Liang SF, Huang GK, Wang YQ, Tu XY, Zhang YN, Li S, Liu T, Cheng BB. Autophagy plays a pro-apoptotic role in arsenic trioxide-induced cell death of liver cancer. J Integr Med. 2024; 22(3): 295–302.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
自噬在三氧化二砷诱导的肝癌细胞死亡中发挥促进凋亡的作用
目的:三氧化二砷(As2O3)对肝细胞癌的影响已被广泛报道。自噬在癌细胞的存活和死亡过程中发挥着双重作用。因此,我们研究了自噬在 As2O3 诱导的肝癌细胞凋亡中的确切作用。使用流式细胞仪、Hoechst 33258 染色法和 TUNEL 检测法评估了经 As2O3 处理的肝癌细胞的凋亡率。结果用 As2O3 处理 HepG2 和 SMMC-7721 细胞后,其存活率呈时间和剂量依赖性下降。流式细胞仪显示,两种肝癌细胞株的凋亡率随 As2O3 浓度的增加而增加。经 As2O3 处理的肝癌细胞的凋亡还表现为 caspase cascade 的激活和 Bcl-2/Bax 的表达调节。此外,As2O3 还能诱导肝癌细胞自噬;这一发现得到了 Western 印迹、LC3-II 和 beclin 1 免疫荧光以及透射电子显微镜的支持。在肝癌细胞中,As2O3 可抑制磷脂酰肌醇3-激酶/蛋白激酶B/哺乳动物雷帕霉素靶标(PI3K/AKT/mTOR)信号通路,该信号通路在细胞凋亡和自噬中都发挥着重要作用。PI3K 激活剂 SC-79 部分逆转了 As2O3 诱导的自噬和细胞凋亡。此外,用 3-甲基腺嘌呤抑制自噬可部分逆转 As2O3 对细胞活力的负面影响。结论As2O3能诱导肝癌细胞凋亡和自噬。As2O3诱导的自噬可能具有促凋亡作用,有助于降低肝癌细胞的存活率。该研究为As2O3对肝癌的影响提供了新的见解:Deng ZT, Liang SF, Huang GK, Wang YQ, Tu XY, Zhang YN, Li S, Liu T, Cheng BB.自噬在三氧化二砷诱导的肝癌细胞死亡中发挥促凋亡作用J Integr Med.2024; 22(3):295-302.
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Integrative Medicine-Jim
Journal of Integrative Medicine-Jim Medicine-Complementary and Alternative Medicine
CiteScore
9.20
自引率
4.20%
发文量
3319
期刊介绍: The predecessor of JIM is the Journal of Chinese Integrative Medicine (Zhong Xi Yi Jie He Xue Bao). With this new, English-language publication, we are committed to make JIM an international platform for publishing high-quality papers on complementary and alternative medicine (CAM) and an open forum in which the different professions and international scholarly communities can exchange views, share research and their clinical experience, discuss CAM education, and confer about issues and problems in our various disciplines and in CAM as a whole in order to promote integrative medicine. JIM is indexed/abstracted in: MEDLINE/PubMed, ScienceDirect, Emerging Sources Citation Index (ESCI), Scopus, Embase, Chemical Abstracts (CA), CAB Abstracts, EBSCO, WPRIM, JST China, Chinese Science Citation Database (CSCD), and China National Knowledge Infrastructure (CNKI). JIM Editorial Office uses ThomsonReuters ScholarOne Manuscripts as submitting and review system (submission link: http://mc03.manuscriptcentral.com/jcim-en). JIM is published bimonthly. Manuscripts submitted to JIM should be written in English. Article types include but are not limited to randomized controlled and pragmatic trials, translational and patient-centered effectiveness outcome studies, case series and reports, clinical trial protocols, preclinical and basic science studies, systematic reviews and meta-analyses, papers on methodology and CAM history or education, conference proceedings, editorials, commentaries, short communications, book reviews, and letters to the editor. Our purpose is to publish a prestigious international journal for studies in integrative medicine. To achieve this aim, we seek to publish high-quality papers on any aspects of integrative medicine, such as acupuncture and traditional Chinese medicine, Ayurveda medicine, herbal medicine, homeopathy, nutrition, chiropractic, mind-body medicine, taichi, qigong, meditation, and any other modalities of CAM; our commitment to international scope ensures that research and progress from all regions of the world are widely covered. These ensure that articles published in JIM have the maximum exposure to the international scholarly community. JIM can help its authors let their papers reach the widest possible range of readers, and let all those who share an interest in their research field be concerned with their study.
期刊最新文献
A comprehensive overview on antiviral effects of baicalein and its glucuronide derivative baicalin. Effectiveness and safety of adjunctive non-drug measures in improving respiratory symptoms among patients with severe COVID-19: A multicenter randomized controlled trial. Luteolin protects against myocardial ischemia/reperfusion injury by reducing oxidative stress and apoptosis through the p53 pathway. Editorial Board Scientific guidelines for preclinical research on potentised preparations manufactured according to current pharmacopoeias—the PrePoP guidelines
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1